The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells - PubMed (original) (raw)

The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells

K Okazaki et al. EMBO J. 1995.

Abstract

The c-mos proto-oncogene product, Mos, is a serine/threonine kinase that can activate ERK1 and 2 mitogen-activated protein (MAP) kinases by direct phosphorylation of MAPK/ERK kinase (MEK). ERK activation is essential for oncogenic transformation of NIH 3T3 cells by Mos. In this study, we examined how mitogenic and oncogenic signalling from the Mos/MEK/ERK pathway reaches the nucleus to activate downstream target genes. We show that c-Fos (the c-fos protooncogene product), which is an intrinsically unstable nuclear protein, is metabolically highly stabilized, and greatly enhances the transforming efficiency of NIH 3T3 cells, by Mos. This stabilization of c-Fos required Mos-induced phosphorylation of its C-terminal region on Ser362 and Ser374, and double replacements of these serines with acidic (Asp) residues markedly increased the stability and transforming efficiency of c-Fos even in the absence of Mos. Moreover, activation of the ERK pathway was necessary and sufficient for the c-Fos phosphorylation and stabilization by Mos. These results indicate that c-Fos undergoes stabilization, and mediates at least partly the oncogenic signalling, by the Mos/MEK/ERK pathway. The present findings also suggest that, in general, the ERK pathway may regulate the cell fate and function by affecting the metabolic stability of c-Fos.

PubMed Disclaimer

Cited by

Stress up-regulates neuronal expression of the herpes simplex virus type 2 large subunit of ribonucleotide reductase (R1; ICP10) by activating activator protein 1.
Gober MD, Wales SQ, Hunter JC, Sharma BK, Aurelian L. Gober MD, et al. J Neurovirol. 2005 Aug;11(4):329-36. doi: 10.1080/13550280591002423. J Neurovirol. 2005. PMID: 16162476
Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
Bossis G, Malnou CE, Farras R, Andermarcher E, Hipskind R, Rodriguez M, Schmidt D, Muller S, Jariel-Encontre I, Piechaczyk M. Bossis G, et al. Mol Cell Biol. 2005 Aug;25(16):6964-79. doi: 10.1128/MCB.25.16.6964-6979.2005. Mol Cell Biol. 2005. PMID: 16055710 Free PMC article.
Quantitative analysis of ERK2 interactions with substrate proteins: roles for kinase docking domains and activity in determining binding affinity.
Burkhard KA, Chen F, Shapiro P. Burkhard KA, et al. J Biol Chem. 2011 Jan 28;286(4):2477-85. doi: 10.1074/jbc.M110.177899. Epub 2010 Nov 22. J Biol Chem. 2011. PMID: 21098038 Free PMC article.
Temporal production of the signaling lipid phosphatidic acid by phospholipase D2 determines the output of extracellular signal-regulated kinase signaling in cancer cells.
Zhang F, Wang Z, Lu M, Yonekubo Y, Liang X, Zhang Y, Wu P, Zhou Y, Grinstein S, Hancock JF, Du G. Zhang F, et al. Mol Cell Biol. 2014 Jan;34(1):84-95. doi: 10.1128/MCB.00987-13. Epub 2013 Oct 28. Mol Cell Biol. 2014. PMID: 24164897 Free PMC article.
Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer.
Liu R, Zhang T, Zhu G, Xing M. Liu R, et al. Nat Commun. 2018 Feb 8;9(1):579. doi: 10.1038/s41467-018-03033-1. Nat Commun. 2018. PMID: 29422527 Free PMC article.

References

1. J Biol Chem. 1991 Apr 5;266(10):6007-10 - PubMed
1. Jpn J Cancer Res. 1991 Mar;82(3):250-3 - PubMed
1. J Exp Zool. 1971 Jun;177(2):129-45 - PubMed
1. Virology. 1973 Apr;52(2):456-67 - PubMed
1. J Virol. 1979 Aug;31(2):514-21 - PubMed

The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells - PubMed (original) (raw)